Insiders · KTTA

KTTA insider transactions

Pasithea Therapeutics Corp. (KTTA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

KTTA insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Pasithea Therapeutics Corp., latest first. Follow anyone to get their next filing.

• Coastlands Capital LP10% owner, since April 2026+$53K
• Tiago MarquesChief Executive Officer, Director+$25K-$792
• Lawrence SteinmanDirector+$113K
• Simon DumesnilDirector+$25K
• Daniel H SchneidermanChief Financial Officer, since August 2022
• Kartik KrishnanChief Medical Officer, since May 2026
• Emer LeahyDirector
• Alfred J NovakDirector, since September 2022
• Graeme Martin CurrieChief Development Officer, since July 2023
• PD Joint Holdings, LLC Series 2016-A10% owner, since October 2022
• David DelaneyInsider, since August 2022+$1,110
• Eric ShahinianInsider, since August 2022+$391K
• Avi GellerInsider, since August 2022+$70.9K
• Leonite Fund I, LPInsider, since August 2022
• Israel Maxx AbramowitzInsider, since September 2021
• Dean LazerInsider, since September 2021
• Eric LazerInsider, since September 2021

Recent Form 3, 4, and 5 filings for KTTA

• 140d
  Large owner Coastlands Capital Lp bought $53,000 worth of shares (100,000 units at $0.53) (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Chief Executive Officer Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Director Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Director Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Chief Financial Officer Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Chief Medical Officer Krishnan Kartik

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Director Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 4 filed by Director Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 188d
  SEC Form 3 filed by new insider Krishnan Kartik

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 206d
  SEC Form 3 filed by new insider Coastlands Capital Lp

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 343d
  Director Steinman Lawrence bought $100,000 worth of shares (133,333 units at $0.75), increasing direct ownership by 201% to 199,691 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 343d
  Chief Financial Officer Schneiderman Daniel H was granted 26,667 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 343d
  Chief Executive Officer Marques Tiago bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 83% to 73,334 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 343d
  Director Dumesnil Simon bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 1,333% to 35,833 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 343d
  Director Leahy Emer was granted 33,333 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Director Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Chief Financial Officer Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Chief Executive Officer Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Director Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Director Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 378d
  SEC Form 4 filed by Director Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 544d
  Chief Executive Officer Marques Tiago sold $792 worth of shares (960 units at $0.82), decreasing direct ownership by 2% to 40,001 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 878d
  Director Novak Alfred J was granted 3,500 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Marques Tiago (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Schneiderman Daniel H (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Dumesnil Simon (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Leahy Emer (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Novak Alfred J (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 948d
  SEC Form 4 filed by Currie Graeme Martin (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 983d
  SEC Form 4 filed by Currie Graeme Martin

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1225d
  SEC Form 3 filed by new insider Currie Graeme Martin

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1252d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1252d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1364d
  SEC Form 3: New insider Pd Joint Holdings, Llc Series 2016-A claimed ownership of 2,608,696 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1442d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,287,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1442d
  SEC Form 4: Marques Tiago was granted 9,206 shares, increasing direct ownership by 1% to 819,206 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1448d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,282,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1453d
  SEC Form 4: Dumesnil Simon was granted 50,000 shares

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1475d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,277,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1477d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1480d
  SEC Form 4: Marques Tiago was granted 5,000 shares, increasing direct ownership by 0.62% to 810,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1482d
  SEC Form 4: Delaney David bought $1,110 worth of shares (1,000 units at $1.11)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1484d
  SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1489d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1501d
  SEC Form 4: Shahinian Eric bought $76,299 worth of shares (64,357 units at $1.19)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1511d
  SEC Form 3 filed by new insider Novak Alfred J

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1525d
  SEC Form 4: Shahinian Eric bought $100,367 worth of shares (88,901 units at $1.13)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1531d
  SEC Form 4: Shahinian Eric bought $26,293 worth of shares (22,828 units at $1.15)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1536d
  SEC Form 4: Geller Avi bought $70,939 worth of shares (54,644 units at $1.30)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1536d
  SEC Form 3 filed by new insider Leonite Fund I, Lp

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1544d
  SEC Form 4: Shahinian Eric bought $188,283 worth of shares (155,773 units at $1.21)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1546d
  SEC Form 3: New insider Delaney David claimed ownership of 226,521 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1547d
  SEC Form 3 filed by new insider Schneiderman Daniel H

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)